CDTX insider trading

CIK 1610618

Cidara Therapeutics, Inc.: insider trade history from SEC Form 4 filings.

Form 4 trades
195
Last 90 days
0
Buys / sells
21% / 22%
Insiders
28

CDTX insider activity at a glance

FilingIQ tracks 195 insider transactions for CDTX in filings since Apr 21, 2015. The most recent transaction is dated Jan 7, 2026. They were reported by 28 insiders.

Across the full history, 41 open-market purchases and 42 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.

Latest CDTX Form 4 filings

Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.

Tickers with similar insider activity

Ranked next to CDTX by Form 4 lines in the last 90 days, the number on each card.

Frequently asked

How many insider trades does FilingIQ track for CDTX?
FilingIQ tracks 195 Form 4 insider transactions for CDTX (Cidara Therapeutics, Inc.), covering filings from Apr 21, 2015 onwards. 0 of those are dated within the last 90 days.
Are CDTX insiders net buyers or net sellers?
Across the full Form 4 history for CDTX, 41 transactions (21%) were open-market purchases and 42 (22%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CDTX insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.

Methodology & sources

Every CDTX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Institutional holder counts come from the quarter's SEC Form 13F reports. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.